Filters
Documents
Showing 25 of 828 items meeting your criteria.
| Type | Category | Supplier | ||
|---|---|---|---|---|
 | Krishgen Biosystems provide sensitive, validated ELISA kits as a solution for your cytokine testing. | |||
Documents | ELISA | Krishgen Biosystems | ||
 | Krishgen offers a range of ELISAs to quantify bispecific antibody drug levels accurately and quickly in serum and plasma samples. | |||
Documents | ELISA | Krishgen Biosystems | ||
 | Discover iXCells collection of primary vascular cells sourced from both human and animal tissues, accompanied by supporting media. Our range includes cells from cardiac, cardiac microvascular, umbilical vein, dermal, and other vascular origins. | |||
Documents | Primary Cells | iXCells Biotechnologies | ||
 | iXCells streamlined custom iPSC generation services liberate you from the demanding and labour-intensive task of cell reprogramming and gene editing, allowing you to focus on research. | |||
Documents | Service | iXCells Biotechnologies | ||
 | iXCells renal cell models offer accurate and reliable insights, enabling researchers to study kidney function, disease mechanisms, and potential therapeutic interventions. | |||
Documents | Primary Cells | iXCells Biotechnologies | ||
 | iXCells offers custom cell isolation services for a variety of cell types obtained from ethically procured donor tissues according to your specific criteria. | |||
Documents | Primary Cells | iXCells Biotechnologies | ||
 | Accelerating neurological research, drug screening, and disease modelling with a wide range of Human iPSC-Derived Cells – supported by research publications and trusted by researchers, scientists, academia, and global organizations.
Primary Cell Products designed to empower researchers with innovative solutions that accelerate drug discovery workflows, with a focus on neurodegenerative and central nervous system diseases. | |||
Documents | Neuroscience | iXCells Biotechnologies | ||
 | Since its inception in 1998, AllCells has been providing primary cell products to support the cell and gene therapy industry. In 2022, AllCells joined Discovery Life Sciences to expand its capabilities and serve the entire cell and gene therapy continuum — from basic discovery through commercialisation. With more than 30 years of collective industry experience, AllCells and Discovery will focus on providing revolutionary products and services with greater speed and reliability. | |||
Documents | Human Blood Products | AllCells | ||
 | Sourcing high-quality cellular material is one of the biggest industry challenges for the development of cell and gene therapies. AllCells, a Discovery Life Sciences company, is the industry leader in providing GMP-compliant and RUO starting materials to support the full continuum of cell and gene therapy production – from basic discovery through commercialisation. Operating the largest and most diverse repository of healthy, recallable donors, AllCells is well-suited to fulfil a variety of donor attributes. | |||
Documents | Human Blood Products | AllCells | ||
 | Mobilized Leukopaks are apheresis products collected from healthy donors treated with different FDA-approved drugs to stimulate mobilization of CD34+ hematopoietic stem and progenitor cells (HSPCs) from the bone marrow to the peripheral blood. This procedure results in large-scale yields of single-donor CD34+ HSPCs, allowing for scalability and reproducibility of experiments by limiting the impact of donor-to-donor variability. | |||
Documents | Human Blood Products | AllCells | ||
BeCytes Biotechnologies is a biotechnological company that offers products and services (CRO) based on tissue procurement, cell isolation and cell solutions for in vitro models for research purposes.
BeCytes Biotechnologies offers an extensive portfolio of cryopreserved human and animal liver cells, including plateable and suspension hepatocytes, stellates, Kupffers, liver sinusoidal endothelial cells and sub-cellular liver fractions. | ||||
Videos | Primary Cells | BeCytes Biotechnologies | ||
 | ProSci offers single domain antibody development services. ProSci has 25+ years of developing antibodies, developed 20,000+ custom antibodies, and offers customisable services tailored to specific needs. | |||
Documents | Antibodies | ProSci | ||
 | The Single Doman Antibody (sdAb) from camelid, also known as VHH antibodies, provides cutting edge technology for antibody research. sdAbs lack light chains and are smaller and more stable than conventional antibodies, yet they possess fully functional antigen-binding capability. Due to its size (a mere 15 kDa), a single domain antibody is adept at reaching otherwise inaccessible epitopes. | |||
Documents | Antibodies | ProSci | ||
 | ProSci has developed SARS-CoV-2 pseudoviruses with a luciferase reporter allowing researchers to quickly build their own neutralization and inhibitor interaction assays. These pseudoviruses have been engineered to lack the appropriate coding for the virus to replicate. | |||
Documents | COVID-19 | ProSci | ||
 | Single domain antibodies (sdAbs) are small antigen-binding fragments with unique characteristics that make them useful alternatives to conventional antibodies and important tools in research, diagnostics and therapeutics. | |||
Documents | Antibodies | ProSci | ||
 | The SARS-CoV-2 virus which causes COVID-19 is comprised of 10 open reading frames (ORFs). Many of these create structural proteins and nonstructural proteins, but several of them generate unique proteins named after the ORF they are encoded by. Inhibiting some of these SARS-CoV-2 proteins which contribute to viral immune evasion could lead to faster clearing of SARS-CoV-2 infection by improving the hosts antiviral systems. ProScis catalogue has antibodies and recombinant proteins to many of the SARS-CoV-2 ORF accessory proteins. | |||
Documents | COVID-19 | ProSci | ||
 | BeCytes Biotechnologies supports life science researchers developing preclinical studies, aimed to improve human health, by providing access to primary human liver cells. | |||
Documents | Primary Cells | BeCytes Biotechnologies | ||
 | LeadGene specialises in the design and development of high-quality antibodies & proteins. View their product catalogue here. | |||
Documents | Catalogue | LeadGene Biomedical | ||
 | Cytokines for cell therapy diagram flyer | |||
Documents | Cytokines | LeadGene Biomedical | ||
 | XenoForm Tumour Gel is made from synthetic biological materials, which can provide an extracellular matrix microenvironment without the risk of zoonotic pathogens or toxins. It has high activity, stability, biocompatibility, and safety, and can be operated at room temperature. It is also easy to inject and allows self-adjustment of gel density. This product can be used in tumour growth experiments with various mouse cancer models. | |||
Documents | Cancer | LeadGene Biomedical | ||
 | The 3D cell culture hydrogel system simulates the microenvironment of human tissue using synthetic biological materials. It is stable, adjustable, easy to operate, and has high biological compatibility, which can be applied in 3D cell culture, tumour formation experiments, tumour angiogenesis and invasion study. | |||
Documents | Cell Culture | LeadGene Biomedical | ||
 | BeCytes Biotechnologies has created a platform capable of coordinating the donation of human tissues and cells for biomedical research purposes. It encompasses strong collaborations with national and international procurement centres, biobanks and hospitals, allowing them to provide researchers with a wide range of tissue samples. | |||
Documents | Service | BeCytes Biotechnologies | ||
 | CHP Applications - Fibrotic Conditions | |||
Documents | Peptides | 3Helix | ||
 | CHP Applications - Skeletal Disease and Development | |||
Documents | Peptides | 3Helix | ||
 | Empowering Collagen Targeting for the Diagnosis and Treatment of Human Conditions | |||
Documents | Peptides | 3Helix | ||